CHE vs FMS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CHE · Chemed$548.59 ▼ 0.50%
FMS · Fresenius Medical Care$20.44 ▲ 1.54%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CHE +26.4%
- FMS -4.3%
Head to head
| Metric | CHE | FMS |
|---|---|---|
| Price | $548.59 | $20.44 |
| Change today | ▼ 0.50% | ▲ 1.54% |
| Market cap | $7.11B | $10.61B |
| Return, 3 months | +3.7% | -13.1% |
| Return, year to date | +28.7% | -10.7% |
| Return, 1 year | +27.4% | -9.2% |
| P/E (TTM) | 26.3 | 12.5 |
| P/B | 8.3 | 0.8 |
| P/E percentile vs own 5y | 31st | 21st |
| Dividend yield | 0.46% | 4.14% |
| Revenue growth (YoY, latest qtr) | +10.6% | +1.1% |
| Net profit growth (YoY) | +11.5% | -31.3% |
| Gross margin | 33.5% | 26.5% |
| Operating margin | 14.0% | 10.0% |
| Net margin | 10.6% | 4.2% |
| Return on equity | 29.1% | 6.4% |
| Analyst target vs. price | +11.6% | +17.4% |
| Analyst buy share | 60% | 0% |
| RSI (14) | 61 | 37 |
| 30-day volatility | 24.8% | 37.9% |
| Max drawdown, 1 year | -23.0% | -21.7% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- FMS is the largest of the group by market value.
- CHE has returned the most over the past year.
- FMS carries the lowest trailing P/E.
- FMS pays the highest dividend yield.
- CHE is growing revenue fastest.
- CHE keeps the most profit per dollar of sales.
- CHE has been the calmest stock over the last 30 days.